Long-Term Follow-Up of Chronic Hepatitis C Patients Treated with Interferon-Alpha: Risk of Cirrhosis and Hepatocellular Carcinoma in a Single Center over 10 Years

Publisher： Karger

E-ISSN： 1423-0100|58|1|14-21

ISSN： 0300-5526

Source： Intervirology, Vol.58, Iss.1, 2015-01, pp. : 14-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Liver cancer in Wilson disease

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 3, 2015-03 ,pp. : 535-539

John Wiley & Sons Inc

Access to resources Recommend Favorite

Low-Dose, Long-Term, Intermittent Interferon-alpha-2b Therapy after Radical Treatment by Radiofrequency Ablation Delays Clinical Recurrence in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma

By  

Intervirology, Vol. 48, Iss. 1, 2005-03 ,pp. : 64-70

Karger

Access to resources Recommend Favorite

Anticarcinogenic Impact of Interferon on Patients with Chronic Hepatitis C: A Large-Scale Long-Term Study in a Single Center

By  

Intervirology, Vol. 49, Iss. 1-2, 2005-09 ,pp. : 82-90

Karger

Access to resources Recommend Favorite

Effect of the Dose and Duration of Interferon-Alpha Therapy on the Incidence of Hepatocellular Carcinoma in Noncirrhotic Patients with a Nonsustained Response to Interferon for Chronic Hepatitis C

By  

Oncology, Vol. 61, Iss. 2, 2001-08 ,pp. : 134-142

Karger

Access to resources Recommend Favorite

Interferon‐free therapy of chronic hepatitis C with direct‐acting antivirals does not change the short‐term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 4, 2018-02 ,pp. : 516-525

John Wiley & Sons Inc

Access to resources Recommend Favorite